vimarsana.com

Latest Breaking News On - Alnylam pharmaceuticals stock - Page 4 : vimarsana.com

The Manufacturers Life Insurance Company Sells 495,795 Shares of Alnylam Pharmaceuticals, Inc (NASDAQ:ALNY)

The Manufacturers Life Insurance Company decreased its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) by 59.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 343,220 shares of the biopharmaceutical company’s stock after selling 495,795 shares during the quarter. […]

Sectoral Asset Management Inc Increases Position in Alnylam Pharmaceuticals, Inc (NASDAQ:ALNY)

Sectoral Asset Management Inc. lifted its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) by 0.6% in the 4th quarter, Holdings Channel.com reports. The firm owned 22,810 shares of the biopharmaceutical company’s stock after purchasing an additional 130 shares during the quarter. Sectoral Asset Management Inc.’s holdings in Alnylam Pharmaceuticals were worth $5,421,000 at […]

Alnylam Pharmaceuticals (NASDAQ:ALNY) Announces Earnings Results, Beats Estimates By $0 57 EPS

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Rating) issued its quarterly earnings results on Thursday. The biopharmaceutical company reported ($1.40) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.97) by $0.57, Briefing.com reports. The business had revenue of $319.29 million during the quarter, compared to analyst estimates of $312.53 million. Alnylam Pharmaceuticals had […]

State Board of Administration of Florida Retirement System Decreases Holdings in Alnylam Pharmaceuticals, Inc (NASDAQ:ALNY)

State Board of Administration of Florida Retirement System lowered its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) by 1.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 137,032 shares of the biopharmaceutical company’s stock after selling […]

Insider Selling: Alnylam Pharmaceuticals, Inc (NASDAQ:ALNY) CFO Sells 977 Shares of Stock

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) CFO Jeffrey V. Poulton sold 977 shares of the business’s stock in a transaction dated Thursday, April 27th. The shares were sold at an average price of $194.59, for a total value of $190,114.43. Following the completion of the transaction, the chief financial officer now owns 11,706 shares […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.